This site is part of the Informa Connect Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 3099067.

Antibody Engineering & Therapeutics Europe
10 - 12 June, 2025
Congress CenterBasel Switzerland

Dr. Matteo Bianchi, PhD
Associate Director Oncology Research at Molecular Partners AG
Speaker

Profile

Dr. Matteo Bianchi is an immuno-biologist with a PhD from the University Children’s Hospital of Zurich, where he specialized in viral-mediated gene therapy and neutrophil innate immunity. Following his doctoral studies, his work at the University of Zurich and Scripps Research in San Diego centered on antigen design in vaccine research against influenza and HIV and the characterization of polyclonal antibody responses by electron microscopy. Dr. Bianchi joined Molecular Partners in 2020, where he has since focused on immuno-oncology, particularly the development of T-cell engagers for targeting both liquid and solid tumors.

Agenda Sessions

  • Multispecific CD3 Switch-DARPin T-Cell Engagers with Increased Specificity, Efficacy, and Safety against Solid Tumors

    16:15